3/31
04:22 pm
hae
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 [Yahoo! Finance]
Low
Report
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 [Yahoo! Finance]
3/31
04:00 pm
hae
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025
Low
Report
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025
3/18
08:06 am
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
3/3
04:40 pm
hae
Haemonetics Announces Executive Leadership Updates [Yahoo! Finance]
Low
Report
Haemonetics Announces Executive Leadership Updates [Yahoo! Finance]
3/3
04:10 pm
hae
Haemonetics Announces Executive Leadership Updates
Low
Report
Haemonetics Announces Executive Leadership Updates
2/24
06:11 am
hae
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
Medium
Report
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
2/24
06:00 am
hae
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
Medium
Report
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
2/15
01:04 am
hae
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/7
10:36 pm
hae
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/7
12:49 pm
hae
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
2/7
11:57 am
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at JMP Securities from $125.00 to $100.00. They now have a "market outperform" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at JMP Securities from $125.00 to $100.00. They now have a "market outperform" rating on the stock.
2/7
08:59 am
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $112.00 to $108.00. They now have a "buy" rating on the stock.
Medium
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $112.00 to $108.00. They now have a "buy" rating on the stock.
2/7
08:41 am
hae
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $68.00 price target on the stock, down previously from $95.00.
Medium
Report
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $68.00 price target on the stock, down previously from $95.00.
2/7
08:23 am
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $108.00 to $95.00. They now have an "outperform" rating on the stock.
Medium
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $108.00 to $95.00. They now have an "outperform" rating on the stock.
2/7
03:14 am
hae
Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... [Yahoo! Finance]
Medium
Report
Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... [Yahoo! Finance]
2/6
11:49 am
hae
Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
2/6
10:13 am
hae
Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates [Yahoo! Finance]
Low
Report
Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates [Yahoo! Finance]
2/6
10:13 am
hae
Haemonetics (HAE) Q3 Earnings Meet Estimates [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Q3 Earnings Meet Estimates [Yahoo! Finance]
2/6
06:57 am
hae
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website [Yahoo! Finance]
Medium
Report
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website [Yahoo! Finance]
2/6
06:00 am
hae
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
High
Report
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
1/14
06:13 am
hae
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
Low
Report
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
1/8
05:03 pm
hae
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Low
Report
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
1/6
06:00 am
hae
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference